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Women comprise 25% of the US HIV epidemic, with many women of reproductive age.There is a need for providers to address the
reproductive needs and desires of women with HIV given that effective antiretroviral therapy has transformed HIV into a chronic
disease. This cross-sectional study shows high rates of partner serodiscordance (61%) and moderate HIV disclosure to partners
(61%). Patients surveyed reported practitioners discuss condoms (94%) and contraception (71%) more often than pregnancy desire
(38%). In our sample, 44%of the surveyedwomen intended future pregnancy, whereas womenwho did not intend future pregnancy
citedHIV/health and serodiscordance as themost common reasons (56% and 35%, resp.).There was no difference in the knowledge
of mother-to-child transmission risk between women who intended or did not intend future pregnancy (𝑝 = 0.71). These results
underline the need for provider training in reproductive counseling to promote risk reduction and education.
1. Introduction
There are 280,000 HIV-infected women and 200,000 het-
erosexual serodiscordant couples living in the United States,
many of whom need reproductive health services [1, 2].
Cross-sectional US studies report varied rates of pregnancy
desire by women across time: from 29% in a nationally
representative survey in 1998 [3] to 59% in an urban sample
in 2010 [4]. A national sample of HIV-infected women from
2007 to 2009 [5] showed high rates (86.4%) of unintentional
pregnancy, suggesting that pregnancy counseling should
extend to all HIV-infected women regardless of stated desire
of future pregnancies.
According to recent US data, over half of the HIV-
infected women are in serodiscordant relationships with
similar reproductive desires to HIV-negative women [5–7].
One-third of women deny any discussion about reproductive
health with their HIV provider [5, 7, 8]. This highlights
the need for HIV providers to discuss strategies to reduce
HIV transmission including ensuring HIV suppression with
antiretroviral therapy (ART), timed conception, and preex-
posure prophylaxis (PrEP) [4].
We seek to examine rates and impact of partner serodis-
cordance, partner HIV disclosure, practitioners’ reproduc-
tive counseling, and mother-to-child transmission (MTCT)
knowledge on HIV-infected women’s reproductive desires at
a large urban HIV clinic in New England.
2. Methods
A convenience sample of 100 English speaking adult HIV-
infected women of reproductive age were enrolled from
March 2012 to March 2014 at the Miriam Hospital Immunol-
ogy Center, a large urban academic clinic serving 1600 HIV-
infected patients in Rhode Island. Women were recruited
consecutively by study personnel at clinic visits to complete
an administered survey and were provided with a $10 retail
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Table 1: Demographics and clinical information for women with HIV of reproductive age.
No reproductive
desire, 𝑛 = 56
Desire for future
children, 𝑛 = 44 𝑝 value
Age: mean (SD) Age at enrollment 39.9 (5.2) 32.6 (7.1) <0.0001
Self-reported race
White 21 (38%) 11 (25%)
0.35Black 12 (21%) 15 (34%)
Hispanic 11 (20%) 11 (25%)
Other or multiple races 12 (21%) 7 (16%)
CD4: mean (SD) Most recent 588 (311) 586 (289) 0.97
AIDS Self-reported AIDS 11 (20%) 6 (14%) 0.44
ART status
Yes 52 (93%) 34 (81%)
0.13No, not indicated∗ 3 (5%) 3 (7%)
No, but indicated 1 (2%) 5 (12%)
Self-reported
HIV symptoms
None 35 (65%) 31 (70%)
0.17Mild 12 (22%) 4 (9%)
Moderate 7 (13%) 9 (20%)
Severe 0 0
Parity: binary Currently having child 51 (91%) 32 (73%) 0.03
Parity: mean (SD)
Pregnancies 4.0 (2.6) 2.9 (2.2) 0.02
Deliveries 2.8 (2.3) 1.9 (1.4) 0.01
Abortions 20 (36%) 16 (36%) 1
∗ART indications at the time of data collection: CD4 count< 500, AIDS defining illness, pregnancy, acute opportunistic infections,Mycobacterium tuberculosis,
HIV-associated nephropathy, and Hepatitis B coinfection when treatment is indicated [9].
gift card as an incentive. The survey is available as a sup-
plemental file (Supplementary Material is available online
at http://dx.doi.org/10.1155/2016/8048457). Exclusion criteria
included current pregnancy, menopause (absent menses >1
year), or hysterectomy. The Miriam Hospital Institutional
Review Board approved all study procedures.
Variables surveyed included self-reported demographics
and clinical characteristics including ART use, sexual history
(including condom and contraceptive use), sexual partners
and HIV disclosure, self-defined HIV symptoms as either
none, mild, moderate, or severe, and desire for future preg-
nancy. Women reported reasons for presence or absence
of future reproductive desire as well as the effect of HIV,
CD4 cell count/viral load (VL), and partner serodiscordance
on their desire for future pregnancy. Participants reported
previous discussions with providers about condom use,
contraception, and desire for future pregnancy. Providers
at the clinic include either internal medicine or obstetrics/
gynecology doctors. Participants were also asked a multiple-
choice knowledge-based question about MTCT. CD4 count
was collected by chart abstraction.
Results are reported using proportions, means, and stan-
dard deviations. Answer to “Do you desire to have more chil-
dren in the future?” determined future reproductive desire.
Continuous data were analyzed using two-tailed Student’s 𝑡-
tests and categorical data with Fisher’s exact/chi squared tests
with significance set at 0.05%. Multivariable logistic regres-
sionwas conducted using purposeful selection [6] with desire
for future pregnancy as dependent variable by including
candidates with 𝑝 values <0.25 (identified by univariate
screen), sequentially removing nonconfounding variables
with 𝑝 > 0.10, and testing each noncandidate for confound-
ing. Results are reported in adjusted odds ratios (AOR) with
95% confidence intervals (CI). We used SAS version 9.4 (SAS
Institute Inc., Cary, NC) for statistical analyses.
3. Results
Of the 102 women whomet inclusion criteria, 2 declined par-
ticipation, citing time constraints.Themean age of this cohort
was 36.7, and self-reported race was 32% white, 27% black,
22% Hispanic, and 19% multiple race, Asians, American
Indians, or others. Table 1 compares demographic and clinical
information in groups with and without desire for future
pregnancy. Women desiring pregnancy were younger (32.6
versus 39.9, 𝑝 < 0.0001) and reported less prior pregnancies
(2.9 versus 4.0, 𝑝 = 0.02) and deliveries (1.9 versus 2.8,
𝑝 = 0.01). Other clinical markers including CD4 cell count,
self-reported HIV symptoms, and AIDS diagnosis were not
statistically different.
Table 2 reports sexual history, fertility desire, and
provider communication. Most women in the study were
sexually active (desire 64% versus no desire 74%, 𝑝 = 0.38).
There were high but similar rates of serodiscordant partner-
ships among sexually active women (desire 69% versus no
desire 71%, 𝑝 = 0.77) with both groups reporting that con-
cern of infecting partner with HIV affected pregnancy plans
(desire 51% versus no desire 33%, 𝑝 = 0.12). Despite these
concerns, only 20% of women with reproductive intent were
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Table 2: Sexual history, fertility desires, and provider communication for women with HIV of reproductive age.
No
reproductive
desire, 𝑛 = 56
Desire for
future
children,
𝑛 = 44
𝑝 value
∗Sexual activity Sexually active 36 (64%) 32 (74%) 0.38
Not sexually active 20 (36%) 11 (26%)
∗∗Partner’s HIV
status
Known: HIV negative 34 (71%) 27 (69%)
0.77Known: HIV positive 10 (21%) 10 (26%)
Unknown 4 (8%) 2 (5%)
∗Shared HIV status
with partner in the
last year
All 28 (57%) 26 (67%)
0.53Some 7 (14%) 6 (15%)
None 14 (29%) 7 (18%)
∗Condom use
100% 33 (59%) 20 (48%)
0.11
75–99% 6 (11%) 5 (12%)
50–74% 3 (9%) 0
25–49% 2 (4%) 3 (7%)
<25% 10 (18%) 14 (33%)
Birth control
method(s)
Barrier 32 (57%) 20 (45%) 0.31
Permanent 15 (27%) 6 (14%) 0.14
None/abstinence/natural 18 (32%) 21 (48%) 0.15
Hormonal contraceptive/long acting reversible contraception 10 (18%) 10 (23%) 0.62
Fertility desire
Do you desire to have children in the future? 0 44 (100%) <0.0001
Do you think you will have children in the future? 2 (4%) 37 (84%) <0.0001
Does your partner desire to have more children? 6 (13%) 29 (83%) <0.001
Are you currently having unprotected sex with the goal of becoming pregnant? 0 10 (23%) <0.0001
Has your HIV diagnosis impacted your plans regarding pursuing pregnancy? 25 (45%) 20 (45%) 1
Have improvements in treatment and intervention made you desire more
children? 6 (11%) 21 (48%) <0.0001
Does your viral load or CD4 count affect your plans to pursue pregnancy? 7 (13%) 8 (18%) 0.39
∗∗∗Does your concern of infecting your (HIV negative) partner with HIV
affect your plans to pursue pregnancy? 16 (33%) 19 (51%) 0.12
Have you considered or used alternative options (not unprotected sex) to
pursue pregnancy? 4 (7%) 8 (20%) 0.11
∗MTCT rate
<1 30 (55%) 29 (66%)
0.715–10% 11 (20%) 7 (16%)
10–20% 3 (5%) 1 (2%)
>25% 11 (20%) 7 (16%)
Healthcare
provider
communication
Has your medical provider talked to you about whether you were interested in
becoming pregnant? 20 (36%) 18 (41%) 0.68
Have you expressed an interest in becoming pregnant to your medical
provider? 3 (5%) 19 (43%) <0.0001
Has your medical provider talked to you about birth control or contraception? 43 (77%) 28 (64%) 0.19
Has your medical provider talked to you about condoms to prevent STDs and
HIV transmission? 52 (93%) 42 (96%) 0.69
Has your medical provider referred you to a reproductive specialist to discuss
methods to pursue pregnancy? 4 (7%) 9 (20%) 0.07
∗
𝑛 = 99 due to omission by one respondent.
∗∗
𝑛 = 87 excluding patients with no sexual partner in the prior year.
∗∗∗
𝑛 = 85 excluding patients with no sexual partner in the prior year and 2 omissions.
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Figure 1: (a) Reasons for not desiring future pregnancy and (b) reasons for desiring future pregnancy.
referred to a reproductive specialist to discuss alternative
methods of pregnancy.
Nondisclosure of HIV status to any partner in the prior
year was relatively high (no desire 29% [𝑛 = 14] versus desire
18% [𝑛 = 7], 𝑝 = 0.53). Condom use rates and type of birth
control in womenwith or without reproductive desire did not
differ (Table 2).
Of 44 women with desire for future pregnancy, 84%
thought they would have a future child and 10 women
(23%) currently reported condomless sex with the goal of
pregnancy. Interestingly, twowomen (4%)who did not report
desire for a future pregnancy reported that they thought
they would have a future child. Just under half of HIV-
infected women reported that their HIV diagnosis impacted
their pregnancy plans regardless of their desire for future
pregnancy (45% versus 45%, 𝑝 = 1). There was no difference
(𝑝 = 0.71) in the knowledge-based MTCT question: “If you
were to become pregnant, what is the probability that your child
will contract HIV with proper medication and medical guid-
ance?”
Provider rates of discussion were the highest for condom
use (desire 96% versus no desire 93%, 𝑝 = 0.69) followed
by contraception use (desire 64% and no desire 77%, 𝑝 =
0.19) and the lowest in assessing desire for pregnancy (desire
41% versus no desire 35%, 𝑝 = 0.68). Women desiring
pregnancy were more likely to initiate a discussion with
providers regarding pregnancy intent (42% versus 5%, 𝑝 ≤
0.0001).
Figure 1(a) highlights the reason(s) why women reported
that they do not desire future children: HIV/health (52%),
no desire for children (48%), cost (38%), “too old” (38%),
and fear of an HIV positive child (34%). Figure 1(b) reports
the most common reason(s) to desire a future child: “experi-
encing motherhood” (55%), wanting a child with the current
partner (48%), belief that the child will be HIV negative
(41%), and partner/family desire for child (34%).
Logistic model results identified crude univariate predic-
tors for desire of future pregnancy. Factors that reduced desire
of future pregnancy include age (OR: 0.84, 95% CI: 0.77–
0.90), number of prior pregnancies (OR: 0.82, 95% CI: 0.68–
0.98), current children (OR: 0.26, 95% CI: 0.08–0.81), and
time sinceHIV diagnosis (OR: 0.93, 95%CI: 0.87–0.99). Both
current ART regimen (OR: 3.8, 95% CI: 1.1–13.2) and partner
desire for child (OR: 32.2, 95% CI: 9.4–110.1) increased
likelihood of desiring future pregnancy. Multivariate model
significant predictors were age (AOR: 0.78, 95% CI: 0.68–
0.90) and partner’s desire for child (AOR: 45.3, 95% CI: 8.6–
238.0).
4. Discussion
Our study sample indicated that 44% of the reproductive
aged HIV-infected women desire future pregnancy, 84%
of whom think they will become pregnant. A majority of
our sample reported serodiscordant relationships, and 21%
reported not sharing HIV status with any sexual partner
in the previous year. Women reported discussions with
providers about condoms (94%) and contraception (71%) but
discussed current or future specific reproductive desires less
often (38%).The reported lack of provider counseling for safe
pregnancy planning could lead a patient to believe either that
the provider has bias against pregnancy or that the patient
should not become pregnant.
Our reported rate of reproductive desire is consistentwith
recent US studies [4, 6, 7] but higher than earlier surveys
[3]. This may be due to improvements in HIV treatment
throughout the past decade. The rate of serodiscordance in
the present study is higher than previously reported [3, 10]
and notable as 38% of women reported that fear of infecting
partner affected plans to pursue pregnancy. This highlights
an opportunity for increased counseling on risk-reduction
strategies amongHIV-infected women. In our sample, 10% of
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all women reported current condomless sex with the goal of
pregnancy and only 20%ofwomen desiring future pregnancy
reported referral to a reproductive specialist. This indicates
the need for education about safer serodiscordant partner
conception options. Recent surveys [11, 12] showed provider
variability in awareness of and referrals for PrEP, timed
unprotected intercourse, intrauterine insemination (IUI),
and in vitro fertilization (IVF) highlighting the need for
provider training on these issues.
Our final multivariate model included age and partner
desire for children as significant predictors of desire for future
pregnancies. There are a variety of significant predictors in
previous models, with age being the most consistent [3, 4, 13,
14]. Number of children, length of time since diagnosis, and
ART use were significant in a few models, but we presume
these terms are collinear with age in our model. Partner’s
desire for children is a strong influence on reproductive
desires of women in the US [4, 14] and significant in our
model. This multivariate analysis is significant as it suggests
that HIV-infected women are making decisions regarding
future pregnancies based on similar factors to HIV-negative
women.
Limitations of this study include a small sample size and
cross-sectional study design which is not able to capture
evolving trends in pregnancy desire among HIV-infected
women. However, we were able to include a diverse represen-
tation of race and age in this cohort and did attempt to capture
both prior and future intent of pregnancy among HIV-
infected women. Recruitment of women in their forties could
be viewed as a limitation when generalizing to a younger
cohort; however, 18% of women above forty reported desire
for pregnancy and contributed to descriptive endpoints.
5. Conclusions
It is important that each HIV-infected woman receive com-
prehensive reproductive health counseling, including assess-
ment of pregnancy desire with defined discussions on repro-
ductive intent. These conversations can be an opportunity
to identify serodiscordant couples, assess disclosure of HIV
status to sexual partners, and initiate education regarding
safer options to avoid or reduce partner and vertical transmis-
sion such as PrEP, timed unprotected intercourse, IUI, and
IVF. Incorporating training modules for providers managing
reproductive aged HIV-infected women’s HIV and overall
primary care could improve counseling rates and reduce
HIV transmission risk.
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